Novo Nordisk's new CagriSema obesity drug trial to begin on Feb. 10, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
The truth about alcohol and your health, according to data
Northwell Health partnered with Stacker to examine data from the CDC, Pew, and other sources to compile research on alcohol consumption and its health impact.